To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Cancer Institute for fiscal year 2024.

Bill 118 hr 1975, also known as the "Limitation on Availability of Funds for National Cancer Institute Act," aims to place restrictions on the amount of funds available to the Department of Health and Human Services, specifically the National Institutes of Health National Cancer Institute, for the fiscal year 2024.

The bill seeks to limit the funding allocated to the National Cancer Institute in order to control government spending and prioritize resources in other areas. This limitation on funds could potentially impact the research, programs, and initiatives carried out by the National Cancer Institute in the fight against cancer.

Supporters of the bill argue that it is necessary to ensure fiscal responsibility and accountability within the Department of Health and Human Services. They believe that by placing restrictions on funding, it will force the National Cancer Institute to operate more efficiently and effectively with the resources available. Opponents of the bill, however, are concerned that limiting funds for the National Cancer Institute could hinder important research and advancements in the field of cancer treatment and prevention. They argue that cutting funding could have negative consequences on the progress being made in the fight against cancer. Overall, Bill 118 hr 1975 raises important questions about the balance between fiscal responsibility and the need for continued investment in critical areas such as cancer research. It will be important for lawmakers to carefully consider the potential impacts of this legislation on the National Cancer Institute and the individuals and families affected by cancer.